M&A Deal Summary

MCRA Acquires Vorpal

On March 10, 2022, MCRA acquired medical products company Vorpal

Acquisition Highlights
  • This is MCRA’s 1st transaction in the Medical Products sector.
  • This is MCRA’s 1st transaction in Japan.

M&A Deal Summary

Date 2022-03-10
Target Vorpal
Sector Medical Products
Buyer(s) MCRA
Deal Type Add-on Acquisition

Target

Vorpal

Tokyo, Japan
Vorpal is a full-service virtual subsidiary, enabling international MedTech innovators to enter the Japanese market by providing expert guidance and solutions in opportunity assessment, clinical operations, regulatory affairs, reimbursement, quality and safety management, supply chain, and commercialization. The company also provides Designated Marketing Authorization Holder (D-MAH) services to its clients, which enables foreign manufacturers to comply with legal requirements to market products in Japan while minimizing the initial investment and maintaining control over all strategic options. Key therapeutic areas of expertise include Orthopedics, Cardiology, Imaging, General and Plastic Surgery, Neurology, Urology, ENT, Oncology, Ophthalmology, Dermatology, and Psychiatry. Vorpal was formed in 2013 and is based in Tokyo, Japan.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

MCRA

Washington, District of Columbia, United States

Category Company
Founded 2004
Sector Medical Products
DESCRIPTION

MCRA is an adviser and clinical research organization serving the neuro-musculoskeletal and medical device industries. The company's unique value lies in its industry experience together with its successful integration of five business value creators: regulatory, reimbursement, clinical research, healthcare compliance, and quality assurance. MCRA was formed in 2004 and is based in Washington, DC.


DEAL STATS #
Overall 1 of 1
Sector: Medical Products M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: Japan M&A 1 of 1
Year: 2022 M&A 1 of 1